Table 2. Differential metabolites in rat testis responsive to arsenic exposure.
HMDB ID | Metabolite | Measured MW (Da) | Change | Fold change (Treatment/Control)a |
||
---|---|---|---|---|---|---|
1 mg/L | 5 mg/L | 25 mg/L | ||||
HMDB00687 | L-Leucine | 132.1019 | ↑ | 0.94 ± 0.08 | 0.99 ± 0.10 | 1.82 ± 0.46** |
HMDB00157 | Hypoxanthine | 137.0456 | ↓ | 0.80 ± 0.15* | 0.74 ± 0.10** | 0.48 ± 0.10** |
HMDB00875 | Trigonelline | 138.0502 | ↑ | 4.28 ± 3.15 | 2.67 ± 2.56 | 3.65 ± 2.81* |
HMDB00696 | L-Methionine | 150.058 | ↑ | 0.91 ± 0.14 | 0.98 ± 0.13 | 1.40 ± 0.20** |
HMDB00159 | L-Phenylalanine | 166.0859 | ↑ | 0.98 ± 0.18 | 1.04 ± 0.16 | 2.20 ± 0.83** |
HMDB12247 | L-2,3-Dihydrodipicolinate | 170.0323 | ↓ | 0.96 ± 0.09 | 0.95 ± 0.06 | 0.88 ± 0.11* |
HMDB00158 | L-Tyrosine | 182.0808 | ↑ | 0.91 ± 0.15 | 0.96 ± 0.15 | 1.47 ± 0.26** |
HMDB12150 | 2-Keto-6-acetamidocaproate | 188.0703 | ↑ | 1.01 ± 0.20 | 1.12 ± 0.14 | 1.29 ± 0.40** |
HMDB00201 | L-Acetylcarnitine | 204.1052 | ↑ | 1.23 ± 0.17** | 1.22 ± 0.18** | 3.21 ± 1.78** |
HMDB00195 | Inosine | 269.0874 | ↓ | 0.80 ± 0.14* | 0.74 ± 0.12** | 0.47 ± 0.11** |
HMDB01449 | Allopregnanolone | 319.2627 | ↓ | 0.78 ± 0.20 | 0.71 ± 0.41 | 0.36 ± 0.28** |
HMDB03128 | Cortolone | 367.2601 | ↓ | 0.64 ± 0.27 | 0.56 ± 0.25* | 0.30 ± 0.21** |
HMDB11487 | LysoPE(0:0/20:4(5Z,8Z,11Z,14Z)) | 502.2921 | ↑ | 1.80 ± 0.86 | 1.47 ± 0.38* | 1.96 ± 0.90* |
aThe change of metabolite abundance is expressed as the average ratio of treatment/control (control = 1, mean ± SD). A value >1 represents up-regulation, whereas a value <1 indicates down-regulation. *p < 0.05, **p < 0.01.